Your Shoulder, Your Eyes, Your Gums. Nobody Mentioned Any of Them.

Body  ·  17 min read  ·  Which of the odd symptoms have published evidence behind them, which are still uncertain, and the ones that belong at an appointment this week

Weird perimenopause symptoms are usually one hormonal change showing up in tissue nobody associates with menopause. What is documented, what is still uncertain, and which ones are not perimenopause at all.

The shoulder went first. You reached back for the seatbelt in February and something caught, and by April you could not fasten your own bra without turning your whole body. The physiotherapist said frozen shoulder, forties to sixties, very common, nobody really knows why.

Then the eyes. Gritty by four in the afternoon, worse on the screen, worse in the car. You bought drops.

Then the gums started stinging in the mornings, and your cholesterol came back higher than it has ever been on a year you ate better than you have in a decade, and your heart did that flutter thing in the supermarket queue.

Four different appointments. Four different specialists. Nobody asked about your periods.

The short answer: most of the symptoms women describe as weird perimenopause symptoms are not separate problems that happened to arrive together. They are one falling hormone showing up in tissue that also carries receptors for it, which includes joints, tendons, skin, the tear film, the lining of the mouth, the bladder and the vascular system. Some of those connections are well documented. Some are reported constantly by women and barely studied. This page separates the two, because the difference matters when you are deciding what to take to a doctor.

Are weird perimenopause symptoms actually connected, or does it just feel that way?

They are usually connected, and the reason is unglamorous: estrogen is not only a reproductive hormone. Receptors for it appear in tissue throughout the body, and when the supply of estrogen becomes erratic and then falls, every one of those tissues is working under different conditions than it was five years ago.

That is the whole mechanism. There is no need for a more exotic explanation, and there is no need for fourteen separate diagnoses.

What makes it feel like fourteen separate problems is the way medicine is organised. The shoulder goes to orthopaedics. The eyes go to an optometrist. The gums go to a dentist. The cholesterol goes to a GP, the flutter goes to a cardiologist, and each of those appointments is fifteen minutes long and correctly focused on the part of you in front of them. Nobody is doing anything wrong. The pattern is simply invisible from inside any one of those rooms.

It is visible from where you are sitting, which is why the list in your head is more useful than it feels.

Why isn’t the odd stuff on the standard symptom list?

Because the standard list was built around the two symptoms that are easiest to measure and hardest to miss: hot flashes and changes to the cycle. Everything else was historically treated as background noise.

This is worth knowing in detail, because it explains the strangest thing about researching your own symptoms, which is that the internet says there are thirty-four of them and no medical paper says anything of the kind.

The instruments researchers use to measure menopausal symptoms are the Menopause Rating Scale and the Greene Climacteric Scale. The Menopause Rating Scale consists of eleven items.³ The Greene Climacteric Scale, built by examining seven factor-analytic studies to find the symptoms that consistently cluster together, is described in the literature that uses it as a twenty-one item scale.⁴ Neither contains thirty-four of anything. The thirty-four number circulates widely and has no published source behind it.

So the honest position is narrower and more useful than the list: a handful of symptoms are formally measured, a larger group is documented in the research literature without appearing on patient-facing lists, and a third group is reported constantly by women and has almost no evidence either way. Knowing which group a symptom sits in is the difference between a useful appointment and a frustrating one.

Why do the joints, the shoulder and the muscles go together?

Because they are the same tissue problem, and this is the best evidenced of all the odd clusters.

In 2024 a review in Climacteric proposed a collective name for it, the musculoskeletal syndrome of menopause, on the grounds that clinicians were treating arthralgia, muscle loss, falling bone density and progressing osteoarthritis as four unrelated midlife events rather than one hormonal one. The review estimates that more than 70 per cent of women experience musculoskeletal symptoms through the transition and that around 25 per cent are disabled by them.¹

Those are the numbers most worth carrying into an appointment, with one honest caveat attached: the paper is a review that introduces a term and assembles existing evidence, not a new prevalence study, and it describes its own figures as estimates. It is a strong argument, not a measurement.

The pieces of it have their own pages here. Joint pain that arrives in your late forties is the most common entry point. The jar lid that stopped turning is the muscle half. Bone density falls fastest in a specific window, which is the part with a treatment decision attached to it. And frozen shoulder sits at the strange end of this cluster: it overwhelmingly affects women between forty and sixty, which is the observation that started the question, but the evidence is thinner than the coincidence suggests. A 2026 pilot study looking at whether hormone therapy protects against it found a lower rate in the treated group that did not reach statistical significance, and the authors say plainly that larger prospective studies are needed.⁵

That is what an honest answer looks like on this one. The pattern is real. The mechanism is plausible. The proof is not in yet.

Why the eyes, the mouth and the skin at the same time?

Because all three depend on tissue that estrogen helps maintain, and all three change quietly enough that you blame something else first.

The eyes. Dry eye disease occurs more often in women than in men, and the TFOS DEWS II report, an international review of the evidence, attributes that difference in large part to sex steroids and their effect on the ocular surface and the glands that supply it.⁶ It is not that your screen time went up. The tear film changed. The tear film is the part that changes first, which is why drops help less than you expect.

The mouth. Burning mouth syndrome is a chronic pain condition in the oral lining with no visible cause on examination, and it appears predominantly in postmenopausal women. A 2026 systematic review of twenty-two studies found it consistently associated with female sex, menopause and hypothyroidism, while stating that the underlying causes remain poorly understood.⁷ This is a symptom that gets dismissed as anxiety more than almost any other, and the literature does not support dismissing it.

The skin. Collagen loss is the mechanism, and the correlation between skin collagen loss and estrogen deficiency after menopause is described as strong in the connective-tissue literature.⁸ That is the same process behind skin that itches for no visible reason and behind a part that widens before anything else shows.

The Quiet Audit is not about symptoms. It is ten minutes of questions about what you have been absorbing and managing while all of this was happening in the background, which for most women turns out to be the larger load. Start here.

Why does my heart flutter now?

Palpitations in the menopause transition are documented, they were tracked over years rather than asked about once, and the pattern is not uniform.

The Study of Women’s Health Across the Nation followed 3,276 women and identified three trajectories. About half had a sustained low probability of palpitations. About a third had a moderate probability during perimenopause and early postmenopause that then diminished. Just under one in six sat in a high-probability group, and that group had a more adverse health profile at baseline, including vasomotor symptoms, poorer sleep, higher blood pressure and higher perceived stress.²

Two things follow from that. The first is that flutters in this decade are common enough to be unremarkable. The second is that they are not uniformly benign, which is why the palpitations page goes into what is worth checking rather than reassuring you and stopping there.

What is happening to my bladder?

The same estrogen withdrawal, in tissue that the older terminology quietly left out.

Until 2014 the medical term was vulvovaginal atrophy, which described the genital changes and stopped there. A joint terminology conference of the International Society for the Study of Women’s Sexual Health and the North American Menopause Society replaced it with genitourinary syndrome of menopause, explicitly because the condition also involves the urethra and bladder and produces urinary urgency, painful urination and recurrent urinary tract infections.⁹

That change matters to you for a practical reason. If you are going more often, or getting infections you never used to get, that is a listed feature of a named syndrome rather than a separate bladder problem to be managed alone. How often you are actually meant to be going is the page for the detail.

Why did my cholesterol go up in a year I ate better?

Because some cardiovascular risk factors track your age, and a few track your final period specifically.

A SWAN analysis published in the Journal of the American College of Cardiology tested both models against ten years of annual measurements in 1,054 women. Most risk factors followed a straight line consistent with chronological ageing. Total cholesterol, LDL cholesterol and apolipoprotein B did not: they showed substantial increases within the single year before and after the final menstrual period, a pattern consistent with menopause-induced change rather than getting older, and it held across ethnic groups.¹⁰

So the lipid panel that annoyed you was measuring something real, and it was not measuring your diet. The year it happens is the point.

Which of these are documented, and which are only reported?

This is the table to take to an appointment. The right-hand column is not a verdict on whether your symptom is real. It is a note on how much published evidence exists to back you up in the room, which is a different question and a more useful one.

What about the symptoms with no research behind them at all?

They still count, and the way to handle them is different.

For a symptom in the bottom row of that table, a doctor has nothing to read. Arriving with the word perimenopause attached to it invites the conversation to end early, because there is no literature to open. Arriving with the symptom described precisely, dated, and placed next to your cycle history gives the appointment somewhere to go, including the possibility that it is not perimenopause at all.

That is not a lesser answer. A symptom with no evidence base is a symptom that has not been studied, which is a statement about research funding rather than about you.

Is it perimenopause, or is it something else?

Some of it will not be, and the overlap is genuinely difficult, because thyroid disease, iron deficiency, sleep disorders and depression all produce fatigue, cognitive slowing and low mood in exactly this age group.

Four distinctions worth having: how a hormonal low mood differs from the other kind, what a normal blood panel does and does not rule out, why sleep apnea in women hides behind insomnia, and why adrenal fatigue is not the answer despite explaining the feeling so well.

The cognitive side has a hub of its own, because it behaves differently from the physical symptoms on this page and has better evidence behind it: what the transition does to memory, concentration and mood.

When is this worth taking to a doctor?

Some of what is on this page is worth mentioning at your next routine appointment. Some of it is not perimenopause and should be seen regardless of your age or your cycle. The second list is short and specific.

This page is informational and is not medical advice. It describes population-level research findings and cannot assess your own history. See your own clinician.

The two-column page, and the ten minutes it takes

The practical move is one page of paper, written before the appointment rather than in the waiting room.

Left column: every symptom, with the month it started. Not how bad it is. When it began. Right column: your cycle in the same period, at whatever level of detail you have, including the months it was late, early, heavy or missing.

What you are handing over is a timeline, and a timeline is the single piece of evidence a fifteen-minute appointment cannot reconstruct on its own. It is also the thing that makes the connection visible to somebody looking at one organ. Nobody can see the pattern from inside orthopaedics. They can see it on a page.

Frequently asked questions

What are the weird perimenopause symptoms nobody warns you about?
The ones women report most often outside the standard list are joint and muscle pain, frozen shoulder, dry or gritty eyes, burning or stinging in the mouth, itchy skin, hair thinning, palpitations, urinary urgency and recurrent infections, and a sudden rise in cholesterol. The first, the palpitations, the urinary symptoms and the cholesterol rise all have published evidence behind them.¹²⁹¹⁰

Is there really a list of 34 perimenopause symptoms?
Not in the research literature. The instruments used to measure menopausal symptoms are the eleven-item Menopause Rating Scale³ and the Greene Climacteric Scale, described in the literature using it as a twenty-one item scale.⁴ The figure of thirty-four circulates online without a published source.

Can perimenopause cause symptoms before my periods change?
Yes. Perimenopause is characterised by fluctuating rather than steadily falling hormone levels, and the symptoms that follow from fluctuation can appear while cycles still look regular on a calendar. This is a common reason women are told they are too young.

How long do these symptoms last?
It varies enough that an average is misleading, and different symptoms follow different courses; in the palpitations data, for example, the two symptomatic groups both diminished in late postmenopause.² The three real timelines covers what is actually known.

Should I ask for a hormone test?
A single blood test is a poor instrument here, because the defining feature of perimenopause is that levels move unpredictably from day to day. Diagnosis in practice rests on age, cycle pattern and symptoms rather than on one measurement.

Why does everything seem to start at once?

Because the defining feature of perimenopause is not a low level. It is an unstable one.

In the years before the final period, ovarian output becomes erratic. Estrogen does not glide downward in a straight line; it swings, sometimes to levels higher than you saw in your thirties, then drops steeply. Tissue that has spent thirty years under a predictable monthly rhythm is suddenly operating under an unpredictable one, and tissue responds to instability differently from the way it responds to a low but steady supply.

That is why symptoms cluster in bursts rather than accumulating gradually, why a month can be unrecognisably bad and the next one fine, and why the phrase you keep using, that it all started at once, is an accurate description rather than an exaggeration. It also explains the cruelty of the timing: the loudest years of the transition are usually the years when the cycle still looks normal enough that nobody, including you, is connecting anything to it.

The same instability runs underneath the symptoms that do make the standard list. The cycle stops keeping time before it stops altogether. Cramps arrive on schedule with no period behind them. The week before gets worse rather than better, which is often the first sign, and migraines that were manageable for twenty years change character because it is the steepness of the drop, not the level, that triggers them.

What about the night?

The night symptoms deserve separating out, because they are the ones most often treated as a sleep problem and most often are not one.

Temperature regulation happens centrally, and when it becomes unreliable the result is not only the flash you notice in the day. It is waking drenched at a specific hour rather than randomly, and a 3 a.m. waking that is thermal before it is anxious. The order matters: treating the waking as insomnia leads to sleep hygiene advice, while treating it as a temperature event leads somewhere more useful.

Two more that belong here. Restless legs, where the iron status nobody checked is often the relevant number, and alcohol, where the same two glasses now cost more than they did, largely because of what the second half of the night does with them.

And the daytime consequence of all of it: a tiredness that sleep does not fix, which is the symptom most women lead with and the one least likely to get a clear answer.

Does treating it work?

This is where the honest answer gets narrower, because the evidence is symptom-specific rather than general.

Hormone therapy has good evidence for some symptoms, weaker evidence for others, and in several areas on this page there is no trial data at all, only plausibility. That is not a reason to dismiss it and not a reason to expect it to resolve everything. It is a conversation with a clinician who knows your history, and what it does and does not do is the page to read before that conversation rather than after it.

Two adjacent questions come up so often they have their own pages: whether it causes weight gain, where twenty-eight trials point somewhere more reassuring than the reputation, and whether over-the-counter progesterone cream does anything, where the evidence is thinner than the marketing.

Outside hormones, the pattern is familiar: the supplements with the biggest promises tend to have the smallest trials. What the ashwagandha trials actually measured is a reasonable template for how to read the rest of that shelf.

The part nobody puts in the symptom list

You have been running all of this while holding everything else up.

That is not a sentiment, it is the practical reason the symptom list gets managed rather than investigated. A woman who is the one tracking appointments, schedules and everyone else’s deadlines does not stop to book four specialists for herself. She buys the drops, puts a heat pack on the shoulder, moves the cholesterol letter to the pile, and carries on, because stopping costs more than continuing in the short run and nobody is measuring the long run.

The timeline page from a few sections up is a five-minute job. It stays undone for months for the same reason everything else of yours does.

If you want the next quiet step

References
1. Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024;27(5):466-472. pubmed.ncbi.nlm.nih.gov · This is a review that proposes a term and assembles existing evidence; it describes its prevalence figures as estimates rather than new measurements.
2. Carpenter JS, Sheng Y, Pike C, et al. Palpitations across the menopause transition in SWAN: trajectories, characteristics, and associations with subclinical cardiovascular disease. Menopause. 2023;30(1):49-57. pubmed.ncbi.nlm.nih.gov
3. Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health and Quality of Life Outcomes. 2004;2:45. hqlo.biomedcentral.com · The eleven-item count is stated in the paper itself.
4. Greene JG. Constructing a standard climacteric scale. Maturitas. 1998;29(1):25-31. pubmed.ncbi.nlm.nih.gov · The scale’s twenty-one item count is not given in this abstract; it is stated in later research that administers the scale, and is reported here as a secondary source.
5. Reinke EK, et al. A preliminary pilot study to address design issues related to research on potential association of hormone therapy and adhesive capsulitis. Climacteric. 2026. pubmed.ncbi.nlm.nih.gov · Not statistically significant; the authors call for larger prospective studies.
6. Sullivan DA, Rocha EM, Aragona P, et al. TFOS DEWS II Sex, Gender, and Hormones Report. The Ocular Surface. 2017;15(3):284-333. pubmed.ncbi.nlm.nih.gov
7. Qaderi K, et al. Exploring the association between menopause and burning mouth syndrome: an updated review. BMC Oral Health. 2026. pubmed.ncbi.nlm.nih.gov · A systematic review of 22 studies reporting association; it states the underlying causes remain poorly understood.
8. Calleja-Agius J, Brincat M. The effect of menopause on the skin and other connective tissues. Gynecological Endocrinology. 2012;28(4):273-277. pubmed.ncbi.nlm.nih.gov · The authors note that large-scale trials are still needed before firm recommendations can be made.
9. Portman DJ, Gass MLS, on behalf of the Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from ISSWSH and NAMS. Menopause. 2014;21(10):1063-1068. pubmed.ncbi.nlm.nih.gov · This is an expert terminology consensus, not a trial.
10. Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology. 2009;54(25):2366-2373. pubmed.ncbi.nlm.nih.gov

Written by Nora Whitfield for Blue Leaf Journal. Updated: September 20, 2026.